Skip to main content
Clinical Trials/ITMCTR2000003180
ITMCTR2000003180
Recruiting
Phase 4

A multi-centre, prospective, open-lable, observational study for monitoring the safety of Traditional Chinese Medicine granules

First Affiliated Hospital of Guang zhou University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
adverse drug reaction
Sponsor
First Affiliated Hospital of Guang zhou University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
First Affiliated Hospital of Guang zhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who will take TCM granules, which prescribed by the doctor;
  • 2\. Patients who participate in this study voluntarily.

Exclusion Criteria

  • 1\. Patients who won't take TCM granules;
  • 2\. Non\-compliant patients who won't cooperate with follow\-up visit;
  • 3\. Patients who have participated in this study;
  • 4\. Lactating or pregnant women, planning for pregnancy, male or female who lacking effective contraception during the study;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A prospective, open label, multi-centre, observational, post-market study evaluating Juvéderm® Volift with Lidocaine for the correction of moderate to severe nasolabial folds (NLF)gezichtverouderingdermal fillersfacial aging
NL-OMON37130Allergan Pharmaceuticals Ireland23
Recruiting
Not Applicable
An observational registry study of ISAR SUMMIT coronary stent system in coronary artery diseased patients of Indian populatioHealth Condition 1: I251- Atherosclerotic heart disease of native coronary artery
CTRI/2022/07/044472Dr Praveen Chandra
Active, not recruiting
Phase 1
Pharmacokinetics of tacrolimus in the first days after heart and lung transplantatioHeart and lung transplantation, first days after transplantationMedDRA version: 19.0Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 100000004848Therapeutic area: Body processes [G] - Physical Phenomena [G01]
EUCTR2012-001909-24-NLniversity Medical Center Utrecht30
Not yet recruiting
Not Applicable
A multicenter, open, prospective observational study to confirm the clinical efficacy and safety after drug change in patients with degenerative arthritis (spondyloarthritis, knee arthritis) treated with anti-inflammatory analgesicsDiseases of the musculoskeletal system and connective tissue
KCT0007770Yonsei University Health System, Severance Hospital800
Recruiting
Not Applicable
A prospective, multicenter, open-label, observation study evaluating the efficacy and safety of edoxaban in patients with cancer-associated venous thromboembolism
KCT0004697Yonsei University Health System, Severance Hospital300